Leveraging 130 years of knowledge and expertise across the Johnson & Johnson Family of Companies, Johnson & Johnson Medical Devices (JJMD) is proud to launch a new approach to help drive value-based healthcare in hospitals across Europe, Middle East and Africa (EMEA) – CareAdvantage. This is a data-driven, holistic approach in which JJMD partners with hospitals and other healthcare providers to provide a range of benefits, tailored to the customer’s specific needs and priorities.
The healthcare marketplace is changing, with intensifying pressure to meet the ‘triple aim’ of improving outcomes, increasing patient satisfaction and reducing costs. As the focus shifts from volume to value, there is a growing need for new delivery models, resulting in rapid transformation for hospital systems, clinicians and their patients.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8119051-johnson-medical-devices-careadvantage/
As part of its longstanding commitment to Africa, Johnson & Johnson today announced the launch of the Africa Innovation Challenge, an initiative to support Africa’s vibrant and growing innovation ecosystem and to help develop important and locally sustainable consumer health solutions. The challenge is the latest initiative in the company’s comprehensive approach to advancing health and innovation worldwide. The Johnson & Johnson Family of Companies’ presence in Africa dates back more than 80 years and includes business operations, public health programs and corporate citizenship.
“Through the Africa Innovation Challenge, we have the opportunity to support the continent’s top entrepreneurs through mentorship and other resources, and by working together with local talent, to bring forward new solutions to local health care challenges,” said Paul Stoffels, M.D., Executive Vice President and Chief Scientific Officer, Johnson & Johnson.
To view the multimedia release go to:
http://www.multivu.com/players/English/7967451-jnj-africa-innovation-challenge/
The Sounds of Pertussis Campaign moves into action with the second annual Pertussis Awareness Day in New York City featuring a range of educational activities, including the launch of the Sound Off About Pertussis song contest and a new public service announcement (PSA) featuring four-time NASCAR Sprint Cup Series champion Jeff Gordon. The national public awareness campaign encourages parents to help protect themselves and their babies from pertussis—commonly known as whooping cough—by getting vaccinated with an adult Tdap (tetanus, diphtheria, acellular pertussis) booster, which may reduce their risk of getting the disease and spreading it to their babies.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/soundsofpertussis/45203/
Janssen Healthcare Innovation, a team within Janssen Research & Development, LLC (Janssen), today announced Discharge Decision Support System (D2S2) is the winner of the crowdsourcing-inspired Janssen Connected Care Challenge and the $100,000 prize. D2S2 is a discharge decision support system that uses a proprietary algorithm to assemble and score key data upon hospital admission in order to identify patients who should be referred to post-acute care services to reduce the risk of 30-day readmissions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56342-discharge-decision-support-system-janssen-connected-care-challenge
I believe that every child in America has the right to fresh, nutritious school meals, and that every family deserves real, honest, wholesome food. Too many people are being affected by what they eat. It's time for a national revolution. America needs to stand up for better food!
To view Multimedia News Release, go to http://multivu.prnewswire.com/player/43618-jamie-oliver-food-revolution/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
Based on its recent analysis of the nuclear cardiology market, Frost & Sullivan recognizes Siemens Healthcare with the 2011 North America Frost & Sullivan Product Differentiation Excellence of the Year Award for its IQ-SPECT, a distinct imaging solution. This product not only offers high-quality imaging by achieving maximum counts, but does so in the quarter amount of time taken by conventional single photon emission computed tomography (SPECT) systems and with less radiation.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/frostsullivan/53611/
Invacare Corporation (NYSE:IVC), the global leader in home and long-term care medical products, today is launching “Real Life,” a new campaign dedicated to raising awareness of the everyday struggles and achievements of those living with disabilities, ailments or advancing age. For these individuals, even “ordinary” tasks like getting dressed, preparing for the day ahead, caring for children, driving a car or going to work can require extraordinary effort — yet few people are aware of these everyday struggles and achievements. Invacare has created this awareness campaign and platform so that people can share their ‘real life’ stories — or the story of someone who inspires them — for a chance to win cash prizes for themselves and the charity of their choice.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/invacare/49159/
Today the International OCD Foundation (IOCDF), announced their support for children and families suffering from Sudden Onset Obsessive Compulsive Disorder. They are releasing two new PSAs created to bring awareness and engender change surrounding the disorder PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections) and PANS (Pediatric Acute-Onset Neuropsychiatric Syndrome).
To view Multimedia News Release, go to http://www.multivu.com/mnr/54781-ocd-foundation-pandas-psa-obsessive-compulsive-disorder
The CVS Caremark Charitable Trust, a private foundation created by CVS Caremark Corporation (NYSE: CVS) today announced the recipients of the “Innovations in Community Health” grants, which have been awarded to community health centers nationwide through a partnership with the National Association of Community Health Centers (NACHC). The grants will help community health centers increase access to quality health care and produce better health outcomes while reducing costs for patients and healthcare systems.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61405-cvs-caremark-charitable-trust-awards-21-innovations-in-community-health
Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial) diarrhoea in industrialised countries.2 In a report launched today, during a meeting hosted by the European Healthcare and Hospital Federation (HOPE), experts from across Europe highlight the current deficiencies in the management of CDI and outline the steps that are needed to address them.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60637-astellas-report-diagnosis-management-CDI
For the more than 23 million people living with diabetes, blood glucose level testing is critical to maintaining a healthy lifestyle. Singer/songwriter Nick Jonas has type 1 diabetes and personally checks his blood glucose levels up to 12 times a day with the CONTOUR USB® meter. He is working with Bayer Diabetes Care to remind people with diabetes to learn about the importance of blood glucose testing and what has an impact on blood sugar levels, including certain foods, types of exercise, emotions and stress levels. Testing frequently, in accordance with a doctor’s guidance, helps a person with diabetes make important choices throughout the day to stay within a target blood glucose range.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bayer/47240/
